Swiss patent proposal prompts criticism.
作者信息
Burgermeister Jane
出版信息
Nat Biotechnol. 2004 Oct;22(10):1323.
PMID:15521096
Abstract
摘要
相似文献
1
Swiss patent proposal prompts criticism.
Nat Biotechnol. 2004 Oct;22(10):1323.
2
Proposed changes to patent code loom over biotech industry.
Nat Biotechnol. 2007 Dec;25(12):1333-4. doi: 10.1038/nbt1207-1333.
3
US courts narrow patent exemptions.
Nat Biotechnol. 2003 Aug;21(8):834. doi: 10.1038/nbt0803-834.
4
Cabilly patent finale.
Nat Biotechnol. 2008 Aug;26(8):846. doi: 10.1038/nbt0808-846b.
5
India's IP snub.
Nat Biotechnol. 2008 Apr;26(4):362. doi: 10.1038/nbt0408-362b.
6
Negotiating the RNAi patent thicket.
Nat Biotechnol. 2007 Mar;25(3):273-5. doi: 10.1038/nbt0307-273. Epub 2007 Mar 1.
7
US policy may encourage counterfeit drugs.
Nat Biotechnol. 2003 Feb;21(2):121. doi: 10.1038/nbt0203-119.
8
Patent fight sparks biological warfare in the drug industry.
Fortune. 2000 Jul 24;142(3):40, 42.
9
Protecting rights to early-stage technology.
Nat Biotechnol. 2003 Jun;21(6):701-3. doi: 10.1038/nbt0603-701.
10
Owning the secret of life: biotechnology and property rights revisited.
McGeorge Law Rev. 2000 Fall;32(1):111-219.
Zotero 插件